ARN-509: a novel antiandrogen for prostate cancer treatment.
Times cited: 222
Initial clinical trial of a selective retinoid X receptor ligand, LGD1069.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 172
- Constitutive retinoid receptors expressed from adenovirus vectors that specifically activate chromosomal target genes required for differentiation of promyelocytic leukemia and teratocarcinoma cells. Journal of virology. 1996 Academic Article GET IT
- Novel retinoic acid receptor ligands in Xenopus embryos. Proceedings of the National Academy of Sciences of the United States of America. 1996 Academic Article GET IT